Appropriate interpretation of the observed NOACs treatment effect size in real world study

Yang, Wang, Chen, Tao ORCID: https://orcid.org/0000-0002-5489-6450, Dodd, James and Li, Wei (2019) 'Appropriate interpretation of the observed NOACs treatment effect size in real world study'. The American Journal of Medicine, Vol 132, Issue 10, e752-e753.

Preview

Text Appropriate interpretation of the observed NOACs treatment effect size in real-world study.pdf - Accepted Version Download (90kB) | Preview

Abstract

Graham et al recently reported on the comparative effectiveness of warfarin and non-vitamin K antagonist oral anticoagulants (NOACs) among patients with nonvalvular atrial fibrillation. This real-world study was based on Medicare claims data.1 The authors concluded that dabigatran and apixaban were associated with a more favorable benefit-harm profile than rivaroxaban in standard-dose NOAC users.

Item Type:	Article
Additional Information:	Letter
Subjects:	QV Pharmacology > Anti-Bacterial Agents. Tissue Extracts > QV 350.5 Specific drugs, A-Z QV Pharmacology > QV 38 Drug action.
Faculty: Department:	Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI):	https://doi.org/10.1016/j.amjmed.2019.05.030
Depositing User:	Christine Bradbury
Date Deposited:	02 Aug 2019 13:24
Last Modified:	19 Jul 2020 01:02
URI:	https://archive.lstmed.ac.uk/id/eprint/11338

Statistics

View details

Actions (login required)

Edit Item